These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12895162)

  • 1. Health effects of kava use in an eastern Arnhem Land Aboriginal community.
    Clough AR; Jacups SP; Wang Z; Burns CB; Bailie RS; Cairney SJ; Collie A; Guyula T; McDonald SP; Currie BJ
    Intern Med J; 2003 Aug; 33(8):336-40. PubMed ID: 12895162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enough! or too much. What is 'excessive' kava use in Arnhem Land?
    Clough A
    Drug Alcohol Rev; 2003 Mar; 22(1):43-51. PubMed ID: 12745358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava use, dyslipidaemia and biomarkers of dietary quality in Aboriginal people in Arnhem Land in the Northern Territory (NT), Australia.
    Clough AR; Rowley K; O'Dea K
    Eur J Clin Nutr; 2004 Jul; 58(7):1090-3. PubMed ID: 15220953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study of the association between kava use and pneumonia in eastern Arnhem and Aboriginal communities (Northern Territory, Australia).
    Clough AR; Wang Z; Bailie RS; Burns CB; Currie BJ
    Epidemiol Infect; 2003 Aug; 131(1):627-35. PubMed ID: 12948361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver function test abnormalities in users of aqueous kava extracts.
    Clough AR; Bailie RS; Currie B
    J Toxicol Clin Toxicol; 2003; 41(6):821-9. PubMed ID: 14677792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of the association between kava use and ischaemic heart disease in Aboriginal communities in eastern Arnhem Land (Northern Territory) Australia.
    Clough AR; Wang Z; Bailie RS; Burns CB; Currie BJ
    J Epidemiol Community Health; 2004 Feb; 58(2):140-1. PubMed ID: 14729896
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community.
    Mathews JD; Riley MD; Fejo L; Munoz E; Milns NR; Gardner ID; Powers JR; Ganygulpa E; Gununuwawuy BJ
    Med J Aust; 1988 Jun; 148(11):548-55. PubMed ID: 3374423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of substance use in eastern Arnhem Land (Australia): patterns and recent changes.
    Clough AR; Guyula T; Yunupingu M; Burns CB
    Drug Alcohol Rev; 2002 Dec; 21(4):349-56. PubMed ID: 12537704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
    McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
    Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and utility of community health workers' estimation of kava use.
    Clough AR; Baille R; Burns CB; Guyula T; Wunungmurra R; Wanybarrnga SR
    Aust N Z J Public Health; 2002 Feb; 26(1):52-7. PubMed ID: 11895027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities.
    Clough AR; D'Abbs P; Cairney S; Gray D; Maruff P; Parker R; O'Reilly B
    Drug Alcohol Rev; 2004 Dec; 23(4):381-90. PubMed ID: 15763742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy approaches to support local community control over the supply and distribution of kava in the Northern Territory (Australia).
    Clough AR; Jones PJ
    Drug Alcohol Rev; 2004 Mar; 23(1):117-26. PubMed ID: 14965893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory.
    Lee KS; Clough AR; Jaragba MJ; Conigrave KM; Patton GC
    Med J Aust; 2008 May; 188(10):605-8. PubMed ID: 18484938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.
    Brown AC; Onopa J; Holck P; Kaufusi P; Kabasawa D; Craig WJ; Dragull K; Levine AM; Baker JD
    Clin Toxicol (Phila); 2007; 45(5):549-56. PubMed ID: 17503265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccade and cognitive function in chronic kava users.
    Cairney S; Clough AR; Maruff P; Collie A; Currie BJ; Currie J
    Neuropsychopharmacology; 2003 Feb; 28(2):389-96. PubMed ID: 12589393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia.
    Shemesh T; Rowley KG; Jenkins A; Brimblecombe J; Best JD; O'Dea K
    Int J Obes (Lond); 2007 Jan; 31(1):103-8. PubMed ID: 16682979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community.
    McDonald SP; Maguire GP; Duarte N; Wang XL; Hoy WE
    Atherosclerosis; 2004 Dec; 177(2):423-31. PubMed ID: 15530919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year longitudinal study of cannabis users in three remote Aboriginal communities in Arnhem Land, Northern Territory, Australia.
    Lee KS; Conigrave KM; Clough AR; Dobbins TA; Jaragba MJ; Patton GC
    Drug Alcohol Rev; 2009 Nov; 28(6):623-30. PubMed ID: 19930015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in Aboriginal people with heavy episodic patterns of alcohol use.
    Cairney S; Clough A; Jaragba M; Maruff P
    Addiction; 2007 Jun; 102(6):909-15. PubMed ID: 17523985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-streptokinase antibodies and streptokinase resistance in an Aboriginal population in northern Australia.
    Urdahl KB; Mathews JD; Currie B
    Aust N Z J Med; 1996 Feb; 26(1):49-53. PubMed ID: 8775528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.